Vergelijking

Ganirelix vs. Linaclotid

Twee peptiden naast elkaar — identiteit, bewijsbasis, juridische status en bekende bijwerkingen.

Identiteit

Categorie

Onderzoek (overig)

CAS-nr.

123246-29-7

851199-59-2

Molecuulmassa

1570.3 g/mol

1526.74 g/mol

Halfwaardetijd

geen gegevens

Sequentie

geen gegevens

Werkingsmechanisme

Ganirelix

Ganirelix competitively and reversibly binds the pituitary GnRH receptor, rapidly suppressing LH (and, less so, FSH) release — without the initial hormone 'flare' of GnRH agonists.

Linaclotid

Linaclotide activates the guanylate cyclase-C receptor on the luminal surface of the intestinal epithelium. This raises cyclic GMP (cGMP), increases secretion of chloride and bicarbonate into the lumen, raises stool fluid content and accelerates transit; pain signaling is also modulated.

Bewijsbasis

Hoogste bewijs

Humane RCT

Studies

waarvan bij mensen

Geregistreerde effecten

Openstaande tegenstrijdigheden

Gedocumenteerde bijwerkingen

Juridische status

Country	Ganirelix	Linaclotid
Duitsland	Op recept	Op recept
Verenigde Staten	Op recept	Op recept

Volledige vermeldingen

Ganirelix

Volledige vermelding →

Linaclotid

Volledige vermelding →

Frequently asked questions

What is the difference between Ganirelix and Linaclotid?: Ganirelix is classified as "Onderzoek (overig)", while Linaclotid is classified as "Onderzoek (overig)". Ganirelix: Ganirelix is a synthetic decapeptide and GnRH antagonist. In assisted reproduction (IVF) it prevents the premature LH surge during controlled ovarian stimulation. Linaclotid: Linaclotide is a 14-amino-acid peptide and guanylate cyclase-C (GC-C) agonist. It is approved for irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC). This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Ganirelix or Linaclotid?: The highest available evidence level is "Humane RCT" for Ganirelix and "Humane RCT" for Linaclotid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Ganirelix and Linaclotid in Germany and the United States?: Duitsland: Ganirelix — Op recept, Linaclotid — Op recept. Verenigde Staten: Ganirelix — Op recept, Linaclotid — Op recept. These are factual summaries with source and review date on the individual pages.

Country

Ganirelix

Linaclotid

Duitsland

Op recept

Verenigde Staten

Op recept

Frequently asked questions

What is the difference between Ganirelix and Linaclotid?

Ganirelix is classified as "Onderzoek (overig)", while Linaclotid is classified as "Onderzoek (overig)". Ganirelix: Ganirelix is a synthetic decapeptide and GnRH antagonist. In assisted reproduction (IVF) it prevents the premature LH surge during controlled ovarian stimulation. Linaclotid: Linaclotide is a 14-amino-acid peptide and guanylate cyclase-C (GC-C) agonist. It is approved for irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC). This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Ganirelix or Linaclotid?

The highest available evidence level is "Humane RCT" for Ganirelix and "Humane RCT" for Linaclotid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Ganirelix and Linaclotid in Germany and the United States?

Duitsland: Ganirelix — Op recept, Linaclotid — Op recept. Verenigde Staten: Ganirelix — Op recept, Linaclotid — Op recept. These are factual summaries with source and review date on the individual pages.